| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1608 | 2019 |
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1416 | 2018 |
| The global threat of antimicrobial resistance: science for intervention I Roca, M Akova, F Baquero, J Carlet, M Cavaleri, S Coenen, J Cohen, ... New microbes and new infections 6, 22-29, 2015 | 1374 | 2015 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients OA Cornely, M Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, ... Clinical Microbiology and Infection 18, 19-37, 2012 | 1370 | 2012 |
| Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe R Cantón, M Akóva, Y Carmeli, CG Giske, Y Glupczynski, M Gniadkowski, ... Clinical microbiology and infection 18 (5), 413-431, 2012 | 1134 | 2012 |
| DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? JA Roberts, SK Paul, M Akova, M Bassetti, JJ De Waele, G Dimopoulos, ... Clinical infectious diseases 58 (8), 1072-1083, 2014 | 1118 | 2014 |
| Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey MD Tanriover, HL Doðanay, M Akova, HR Güner, A Azap, S Akhan, ... The Lancet 398 (10296), 213-222, 2021 | 1015 | 2021 |
| Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 A Skiada, L Pagano, A Groll, S Zimmerli, B Dupont, K Lagrou, C Lass-Florl, ... Clinical Microbiology and Infection 17 (12), 1859-1867, 2011 | 860 | 2011 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ... Clinical Microbiology and Infection 20, 5-26, 2014 | 771 | 2014 |
| European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on … D Averbuch, C Orasch, C Cordonnier, DM Livermore, M Mikulska, ... haematologica 98 (12), 1826, 2013 | 671 | 2013 |
| European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli … M Paul, E Carrara, P Retamar, T Tängdén, R Bitterman, RA Bonomo, ... Clinical Microbiology and Infection 28 (4), 521-547, 2022 | 580 | 2022 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections MC Arendrup, T Boekhout, M Akova, JF Meis, OA Cornely, O Lortholary, ... Clinical Microbiology and Infection 20, 76-98, 2014 | 520 | 2014 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 509 | 2017 |
| ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ... Clinical Microbiology and Infection 20, 27-46, 2014 | 499 | 2014 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures M Cuenca‐Estrella, PE Verweij, MC Arendrup, S Arikan‐Akdagli, J Bille, ... Clinical Microbiology and Infection 18, 9-18, 2012 | 482 | 2012 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by … WW Hope, E Castagnola, AH Groll, E Roilides, M Akova, MC Arendrup, ... Clinical Microbiology and Infection 18, 38-52, 2012 | 405 | 2012 |
| Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia … A Torres, F Blasi, N Dartois, M Akova Thorax 70 (10), 984-989, 2015 | 400 | 2015 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell … AJ Ullmann, M Akova, R Herbrecht, C Viscoli, MC Arendrup, ... Clinical Microbiology and Infection 18, 53-67, 2012 | 388 | 2012 |
| Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control Y Carmeli, M Akova, G Cornaglia, GL Daikos, J Garau, S Harbarth, ... Clinical Microbiology and Infection 16 (2), 102-111, 2010 | 366 | 2010 |
| Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients M Mikulska, C Viscoli, C Orasch, DM Livermore, D Averbuch, ... Journal of Infection 68 (4), 321-331, 2014 | 351 | 2014 |
